Company profile for Zai Lab

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Headquartered in Shanghai since our founding in 2014, our experienced team has secured partnerships with leading global biopharma companies, generating a broad and late-stage pipeli...
Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Headquartered in Shanghai since our founding in 2014, our experienced team has secured partnerships with leading global biopharma companies, generating a broad and late-stage pipeline of innovative drug candidates. Based on our extensive track record of execution and delivering results.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Shanghai Building 1, 4/F Jinchuang Plaza 4560 Jinke Road Pudong, Shanghai
Telephone
Telephone
+86 21 6163 2588
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251206866125/en/Zai-Lab-Announces-Updates-to-Chinas-National-Reimbursement-Drug-List

BUSINESSWIRE
07 Dec 2025

https://www.businesswire.com/news/home/20251106957927/en/Zai-Lab-Announces-Third-Quarter-2025-Financial-Results-and-Recent-Corporate-Updates

BUSINESSWIRE
06 Nov 2025

https://www.businesswire.com/news/home/20251031556994/en/Zai-Lab-Announces-Participation-in-Investor-Conferences-in-November-and-December-2025

BUSINESSWIRE
31 Oct 2025

https://www.businesswire.com/news/home/20251024903169/en/Zai-Lab-Announces-Updated-Phase-1-Data-for-Zocilurtatug-Pelitecan-formerly-ZL-1310-Demonstrating-Potential-as-a-First-in-ClassBest-in-Class-DLL3-Targeted-ADC-for-Small-Cell-Lung-Cancer-and-Initiation-of-Global-Phase-3-Registrational-Study

BUSINESSWIRE
24 Oct 2025

https://www.businesswire.com/news/home/20251015598260/en/Zai-Lab-to-Announce-Third-Quarter-2025-Financial-Results-and-Recent-Corporate-Updates-on-November-6-2025

BUSINESSWIRE
15 Oct 2025

https://www.businesswire.com/news/home/20251013594159/en/Zai-Lab-Announces-Oral-Presentation-of-Updated-Data-from-Global-Phase-1-Trial-of-Zocilurtatug-Pelitecan-ZL-1310-a-Potential-First-in-Class-DLL3-Targeted-ADC-at-2025-AACR-NCI-EORTC-Conference

BUSINESSWIRE
13 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty